DK0470980T3 - Syntetiske peptider til en HIV-1-vaccine - Google Patents

Syntetiske peptider til en HIV-1-vaccine

Info

Publication number
DK0470980T3
DK0470980T3 DK90906803.3T DK90906803T DK0470980T3 DK 0470980 T3 DK0470980 T3 DK 0470980T3 DK 90906803 T DK90906803 T DK 90906803T DK 0470980 T3 DK0470980 T3 DK 0470980T3
Authority
DK
Denmark
Prior art keywords
hiv
vaccine
synthetic peptides
synthetic
gpkepfrdyvdrfyk
Prior art date
Application number
DK90906803.3T
Other languages
Danish (da)
English (en)
Inventor
Dwo Yuan Charles Sia
Pele Chong
Michel Klein
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Application granted granted Critical
Publication of DK0470980T3 publication Critical patent/DK0470980T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90906803.3T 1989-05-03 1990-05-03 Syntetiske peptider til en HIV-1-vaccine DK0470980T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898910145A GB8910145D0 (en) 1989-05-03 1989-05-03 Synthetic peptides for an hiv-1 vaccine

Publications (1)

Publication Number Publication Date
DK0470980T3 true DK0470980T3 (da) 1994-03-28

Family

ID=10656139

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90906803.3T DK0470980T3 (da) 1989-05-03 1990-05-03 Syntetiske peptider til en HIV-1-vaccine

Country Status (9)

Country Link
EP (1) EP0470980B1 (de)
JP (1) JP2609764B2 (de)
AT (1) ATE102217T1 (de)
CA (1) CA2053921C (de)
DE (1) DE69007099T2 (de)
DK (1) DK0470980T3 (de)
ES (1) ES2062521T3 (de)
GB (1) GB8910145D0 (de)
WO (1) WO1990013564A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
JPH0748276A (ja) * 1992-03-26 1995-02-21 Inmeru:Kk Ｈｉｖ感染症予防ワクチンおよびその製造法
GB9208218D0 (en) * 1992-04-14 1992-05-27 British Bio Technology Hybrid particles
AU693098B2 (en) * 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides
US5693325A (en) * 1994-03-15 1997-12-02 Molecumetics, Ltd. Peptide vaccines and methods relating thereto
CA2202408C (fr) 1994-10-20 2012-03-06 Pierre Charneau Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
FR2731225B1 (fr) * 1995-03-03 2003-10-31 Pasteur Institut Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US5972339A (en) * 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
US7105164B1 (en) 1998-04-07 2006-09-12 Sanofi Pasteur Limited HIV-specific cytotoxic T-cell responses
US6395714B1 (en) 1999-02-24 2002-05-28 Aventis Pasteur Limited Expressing gp140 fragment of primary HIV-1 isolate
JP2007528838A (ja) * 2003-12-24 2007-10-18 ライデン ユニバーシティ メディカル センター 腫瘍特異的ワクチンとしての合成タンパク質
FR2882557A1 (fr) * 2005-02-25 2006-09-01 Centre Nat Rech Scient Epitopes de vih et composition pharmaceutique les contenant
GB0716494D0 (en) * 2007-08-23 2007-10-03 Isis Innovation HIV-2 antigenic peptides
WO2020123964A1 (en) * 2018-12-13 2020-06-18 Labyrx Immunologic Therapeutics (Usa) Limited Labyrinthin-based peptides for cancer immunotherapies and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387915B1 (de) * 1984-10-18 1993-03-10 Institut Pasteur F Antigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen
KR910002374B1 (ko) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Aids 관련질병의 검출을 위한 합성항원
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
JPH0762031B2 (ja) * 1986-12-30 1995-07-05 アメリカ合衆国 エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド
ATE108457T1 (de) * 1987-03-25 1994-07-15 Genetic Systems Corp Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use

Also Published As

Publication number Publication date
EP0470980B1 (de) 1994-03-02
ES2062521T3 (es) 1994-12-16
DE69007099D1 (de) 1994-04-07
ATE102217T1 (de) 1994-03-15
EP0470980A1 (de) 1992-02-19
JPH04502013A (ja) 1992-04-09
GB8910145D0 (en) 1989-06-21
WO1990013564A1 (en) 1990-11-15
JP2609764B2 (ja) 1997-05-14
CA2053921A1 (en) 1990-11-04
DE69007099T2 (de) 1994-06-01
CA2053921C (en) 1999-07-20

Similar Documents

Publication Publication Date Title
AU600466B2 (en) Htlv-iii envelope peptides
GB8910145D0 (en) Synthetic peptides for an hiv-1 vaccine
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
ES2076142T3 (es) Peptidos para el diagnostico de anticuerpos para htlv-iii, su preparacion y uso.
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
CA2164818A1 (en) Tandem synthetic hiv-1 peptides
FI881418A7 (fi) Synteettiset peptidiantigeenit HIV-1 -infektion toteamiseksi.
PT920510E (pt) Quimeras de gnrh-leucotoxina
AR243234A1 (es) Un gen quimerico modificado que codifica una proteina insecticida de bacillus thuringiensis,un vector que lo contiene, y un metodo para mejorar la expresion de un gen heterologo.
IL91007A0 (en) Synthetic vaccine against aids virus
ITFI920052A0 (it) Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
ATE420183T1 (de) Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv
NZ535908A (en) HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
DK0500800T3 (da) Antohæmostatiske Faktor VII-peptider
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
AP9100296A0 (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-1 and HTLV11 viruses.
ATE385805T1 (de) Neue peptide
ES2074591T3 (es) Expresion de polipeptidos de vih 1 y 2 y su utilizacion.
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
ES2176363T3 (es) Peptidos de la proteina gag del vih, su preparacion y su uso.
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
EP0650976A4 (de) Allergenisches peptid.
DE3685636D1 (de) Lysozymbetreffende peptide.